Category: RadiosurgerySyndicate content

ViewRay sets $52m IPO terms

March 13, 2015 by Brad Perriello

ViewRay sets the price range for its pending initial public offering, which would fetch $52 million at the midpoint.

ViewRay sets $52m IPO terms

ViewRay today set the terms for its pending initial public offering, saying it plans to float 4 million shares at $12 to $14 apiece.

At the midpoint of the range, the MRI-guided radiation therapy maker's IPO would fetch $52 million.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Varian to expand in Atlanta, adding 100 jobs

March 10, 2015 by Brad Perriello

Varian Medical Systems says it plans to boost its footprint in Atlanta with a new facility there, adding 100 new jobs in the process.

Varian to expand in Atlanta, adding 100 jobs

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

ViewRay registers for $69m IPO

February 16, 2015 by Brad Perriello

ViewRay registers for an initial public offering worth up to $69 million for its MRIdian cancer detection and radiation treatment device.

ViewRay registers for $69m IPO

ViewRay last week said it plans to raise up to $69 million in an initial public offering for its MRIdian system, which it bills as "the 1st and only MRI-guided radiation therapy system that images and treats cancer patients simultaneously."

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Mevion Medical files for $69M IPO

September 12, 2014 by Brad Perriello

Mevion Medical looks to go public with a $69 million stock offering as it gears up to scale its proton therapy device.

Mevion Medical files for $69M IPO

Mevion Medical registered for a $69 million initial public offering as it gears up to commercialize its proton therapy system.

GPO: Accuray lands 3-year contract with Premier

September 10, 2014 by Arezu Sarvestani

Group purchasing organizations Premier selects radiosurgery devices maker Accuray for an exclusive 3-year contract.

GPO: Accuray lands 3-year contract with Premier

Accuray (NSDQ:ARAY) touted landed a new exclusive contract to offer its CyberKnife M6 and TomoTherapy HDA devices to members of Premier Inc. at special rates.

Accuray settles patent infringement, poaching spat with Best Medical

September 8, 2014 by Brad Perriello

Accuray says it's agreed to settle the patent infringement and poaching lawsuits it had going against Best Medical.

Accuray settles Best Medical patent infringement, poaching spat

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Augmenix raises $11M for surgical hydrogels as Varian's purchase option expires

July 28, 2014 by Arezu Sarvestani

Varian passes on an acquisition option as Augmenix closes a Series D funding round with $10.8 million raised in support of its Space OAR hydrogel for protecting the rectum during prostate radiation therapy.

Augmenix raises $11M for surgical hydrogels

Massachusetts-based Augmenix is hoping it can make it to the U.S. market with the $10.8 million funding round it just closed, the company said this month.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.